Traws Pharma, Inc. (NASDAQ: TRAW)
$8.0950
+0.0250 ( -7.64% ) 0.3K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$8.0950
Previous close
$8.0700
Volume
0.3K
Market cap
$24.42M
Day range
$8.7650 - $8.7650
52 week range
$4.0600 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jul 19, 2024 |
| 8-k | 8K-related | 14 | Jun 28, 2024 |
| pre | Proxies and info statements | 4 | Jun 27, 2024 |
| 8-k | 8K-related | 13 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 20, 2024 |
| 8-k/a | 8K-related | 17 | Jun 17, 2024 |
| 8-k | 8K-related | 14 | May 22, 2024 |
| 8-k | 8K-related | 14 | May 16, 2024 |
| 10-q | Quarterly Reports | 64 | May 15, 2024 |
| 10-k/a | Quarterly Reports | 15 | Apr 29, 2024 |